This article reviews our current understanding and modern treatment of multiple sclerosis
(MS). MS is a disabling condition resulting in devastating social and economic impacts. As …

Multiple sclerosis (MS) is the most prevalent chronic inflammatory disease of the central
nervous system (CNS), affecting more than 2 million people worldwide. It is characterized by …

Abstract Purpose of Review: Despite the efficacy of current therapies for relapsing forms of
multiple sclerosis (MS), there remains a group of patients whose disease fails to respond …

Available therapies for multiple sclerosis patients, while effective during the relapsing phase,
have little benefit for progressive multiple sclerosis patients. Development of therapies to …

Despite the fact that majority of patients with multiple sclerosis (MS) have relapsing-remitting
disease, many transition to secondary progressive disease (SPMS) over time. This transition …

In most cases, multiple sclerosis (MS) begins with a relapsing-remitting course followed by
insidious disability worsening that is independent from clinically apparent relapses and is …

Multiple sclerosis (MS) is an immune-mediated, inflammatory demyelinating disease of the
central nervous system (CNS) that leads to irreversible disability and currently is estimated …

Management of Multiple Sclerosis Relapses : CONTINUUM: Lifelong Learning in Neurology
Account Register Activate Subscription Help Subscribe American Academy of Neurology …

Primary progressive multiple sclerosis (MS) has long been recognised as presenting great
difficulties to our management of what is increasingly a treatable neurological disease. Here …

Multiple sclerosis (MS) has been thought to be a complex and indecipherable disease, and
poorly understood with regards to aetiology. Here, we suggest an emphatically positive view …